需要一种可靠的骨生物标志物来更好地评估慢性肾脏疾病、矿物质和骨疾病

Journal of Parathyroid Disease Pub Date : 2017-09-25 DOI:10.15171/JPD.2018.14

R. Tolouian, Ajay Gupta

{"title":"需要一种可靠的骨生物标志物来更好地评估慢性肾脏疾病、矿物质和骨疾病","authors":"R. Tolouian, Ajay Gupta","doi":"10.15171/JPD.2018.14","DOIUrl":null,"url":null,"abstract":"Chronic kidney disease mineral and bone disorder is a metabolic bone disease present in almost all uremic patients. There are no good markers of bone resorption available for uremic patients. The validity of parathormone as a surrogate marker of bone and mineral disorders has been questioned over the past decade. We need to shift from Surrogate markers to bone markers.","PeriodicalId":16657,"journal":{"name":"Journal of Parathyroid Disease","volume":"79 1","pages":"36-38"},"PeriodicalIF":0.0000,"publicationDate":"2017-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"The need for a reliable bone biomarker to better assess chronic kidney disease mineral and bone disorder\",\"authors\":\"R. Tolouian, Ajay Gupta\",\"doi\":\"10.15171/JPD.2018.14\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Chronic kidney disease mineral and bone disorder is a metabolic bone disease present in almost all uremic patients. There are no good markers of bone resorption available for uremic patients. The validity of parathormone as a surrogate marker of bone and mineral disorders has been questioned over the past decade. We need to shift from Surrogate markers to bone markers.\",\"PeriodicalId\":16657,\"journal\":{\"name\":\"Journal of Parathyroid Disease\",\"volume\":\"79 1\",\"pages\":\"36-38\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-09-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Parathyroid Disease\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15171/JPD.2018.14\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Parathyroid Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15171/JPD.2018.14","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 2

摘要

慢性肾脏疾病矿物质和骨骼紊乱是一种代谢性骨骼疾病，存在于几乎所有尿毒症患者。对于尿毒症患者没有很好的骨吸收指标。在过去的十年里，甲状旁激素作为骨和矿物质疾病的替代标志物的有效性一直受到质疑。我们需要从替代标记转向骨标记。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

The need for a reliable bone biomarker to better assess chronic kidney disease mineral and bone disorder

Chronic kidney disease mineral and bone disorder is a metabolic bone disease present in almost all uremic patients. There are no good markers of bone resorption available for uremic patients. The validity of parathormone as a surrogate marker of bone and mineral disorders has been questioned over the past decade. We need to shift from Surrogate markers to bone markers.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Parathyroid Disease

自引率

0.00%

发文量